Von Willebrand Factor Level Indicate Response to β-Blockers in Cirrhosis: Need a Closer Look!

Affiliations

Comment

Ankur Jindal. Clin Gastroenterol Hepatol. 2022 Jun.

. 2022 Jun;20(6):e1513-e1514.

doi: 10.1016/j.cgh.2021.07.052. Epub 2021 Aug 8.

¹ Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.

No abstract available

Comment in

Reply.
Mandorfer M, Reiberger T, Jachs M. Mandorfer M, et al. Clin Gastroenterol Hepatol. 2022 Jun;20(6):e1514-e1515. doi: 10.1016/j.cgh.2021.08.043. Epub 2021 Sep 4. Clin Gastroenterol Hepatol. 2022. PMID: 34487886 No abstract available.

Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death.
Jachs M, Hartl L, Simbrunner B, Bauer D, Paternostro R, Scheiner B, Schwabl P, Stättermayer AF, Pinter M, Eigenbauer E, Quehenberger P, Trauner M, Reiberger T, Mandorfer M. Jachs M, et al. Clin Gastroenterol Hepatol. 2022 Jun;20(6):1362-1373.e6. doi: 10.1016/j.cgh.2021.07.012. Epub 2021 Jul 10. Clin Gastroenterol Hepatol. 2022. PMID: 34256145